Study: Flu vaccine uptake consistently highest for Asian patients, lowest for Black patients

It's not too late to turn it all around.View Entire Post ›

According to Instagram, Bieber counts the multitasking formula among her empties.View Entire Post ›

“I don’t know that I have ever heard a celebrity talk about a hot flash in the moment. Thank you for being so real.”View Entire Post ›

The Embryolisse Lait-Crème Concentré is a multi-tasking hidden gem of a facial cream.View Entire Post ›

After the model opened up about her experience being diagnosed with type 1 diabetes, we asked experts about the autoimmune condition, the differences between type 1 and type 2 diabetes, and how this diagnosis can change your life.View Entire Post ›

An acupuncturist explains how this scary-looking acupressure mat can help relieve back pain.View Entire Post ›

Depression is a serious disorder that disrupts daily life through lethargy, sleep disturbance, and social withdrawal, and also increases the risk of suicide. The number of depression patients has steadily increased over the years, affecting more than 280 million people worldwide as of 2025. Now, researchers have uncovered a new pathological mechanism that could provide clues for the diagnosis and treatment of depression.

A key switch for cellular energy balance has been discovered in cells, and it could potentially become the target of new therapies for diseases ranging from Parkinson's to rare disorders caused by defects in mitochondria.

New research investigating health outcomes in NCAA athletes during their first year after leaving college sports found that some health measures were worse than expected, but others actually improved.

Denied insurance claims are among the biggest challenges facing the U.S. health care system—driving up costs and leaving providers with billions in unpaid bills.

A new multi-institutional study, led by University Hospitals Connor Whole Health, found that adults with newly diagnosed low back pain with or without sciatica who initially received spinal manipulative therapy administered by a chiropractor were significantly less likely to be diagnosed with opioid use disorder over a two-year follow-up compared to those prescribed ibuprofen.

In a study conducted by the Finnish Institute for Health and Welfare and the University of Helsinki, parents assessed different types of sleep problems in infants: problems associated with total sleep, the number of night awakenings, problems falling asleep and sleep-association disturbances, which refer to difficulties in resettling and falling asleep without parental help after waking up. Prior research on the link between parent–child bond and sleep is scarce, and non-existent in the case of fathers.

Nearly 100 people aboard Royal Caribbean's Serenade of the Seas contracted norovirus during a two-week voyage from San Diego to Miami, the U.S. Centers for Disease Control and Prevention (CDC) said.

Researchers at McGill's Centre of Genomics and Policy (CGP) have launched a first-of-its-kind guide to help Canadian health-care providers offer more inclusive, respectful and affirming care to intersex adults.

If you've been to a medical appointment recently, you may have already interacted with AI. As you describe your symptoms to the doctor, they may ask your permission to use an "AI scribe" to convert audio into medical notes in real time.

Researchers at University of Tsukuba have found that people who have switched jobs are more likely to experience symptoms such as headaches, fatigue, and insomnia, based on the results of an internet survey conducted with approximately 20,000 people in Japan.

Trying to document how single brain cells participate in networks that govern behavior is a daunting task. Brain probes called Neuropixels, which feature high-density silicon arrays, have enabled scientists to collect electrophysiological data of this nature from a variety of animals. These include fish, reptiles, rodents and primates, as well as humans.

A team of researchers have discovered a powerful bispecific inhibitor capable of combating all existing human-pathogenic coronaviruses, including those resistant to existing treatments like Paxlovid. This promising inhibitor, named TMP1, offers hope for more effective and resilient treatments against future outbreaks. A patent has been filed for further exploration in clinical applications.